H.R.2443

Congress: 114th

Sponsor: Representative Guthrie, Brett (05/19/2015)

Committees: House - Energy and Commerce

Description: To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.

Vote Result:

Lastest Action: 05/22/2015 Referred to the Subcommittee on Health. (All Actions)